ENHANCED VIRAL TRANSDUCTION EFFICIENCY
The present disclosure provides, among other things, a method of engineering genetically modified cells comprising, maintaining the cells in a collection chamber, contacting the cells with a fluid flow of a composition comprising viral or non-viral particles, thereby engineering genetically modified...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
10.08.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present disclosure provides, among other things, a method of engineering genetically modified cells comprising, maintaining the cells in a collection chamber, contacting the cells with a fluid flow of a composition comprising viral or non-viral particles, thereby engineering genetically modified cells. The present disclosure also provides, among other things, a method of engineering genetically modified cells comprising, subjecting the cells to a centrifugal force, contacting the cells with a fluid flow of a composition comprising viral or non-viral particles, thereby engineering genetically modified cells. |
---|---|
Bibliography: | Application Number: US202117995211 |